| TAH Drug Code | IRIN4 |
|---|---|
| Indications | Shock, hypersensitivity disorders, bronchial asthma, severe infection |
| Dosing | IV and IM: 4-12 mg (1-3 mL). IVD: 4-20 mg (1-5 mL). INS: 0.4-1 mL for large joint, 0.2-0.5 mL for middle joint, 0.1-0.2 mL for smaller joint. Intra soft tissue: 0.4-6 mg (0.1-1.5 mL). Subconjectival or retrobulbar injection: 0.4-2 mg (0.1-0.5mL). SPI: 1-4 mg(0.25-1 mL). |
| Hepatic Impairment | Dose adjustment not necessary |
| Renal Impairment | Dose adjustment not necessary |
| Contraindications | Peptic ulcer, osteoporosis, psychoses or severe psychoneuroses, active or quiescent TB; acute infection; live vaccines |
| Adverse Effects | Fluid & salt retention, edema, hypertension; amenorrhea, hyperhidrosis; mental disturbances; acute pancreatitis; aseptic osteonecrosis; muscle weakness; Cushingoid state; raised intraocular pressure; visual disturbances; local atrophy; increased appetite; growth retardation. |
| Pregnancy | Compatible |
| Lactation | No (Limited) Human Data - Probably Compatible |
| More Info | UpToDate |